Skip to main content
Clinical Trials/NL-OMON42012
NL-OMON42012
Completed
Not Applicable

Inhalation or nasal corticosteroids and prevalence of hypothalamic-pituitary-adrenal axis suppression in HIV-infected patients - incorporate

niversitair Medisch Centrum Sint Radboud0 sites30 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
adrenal insufficiency
Sponsor
niversitair Medisch Centrum Sint Radboud
Enrollment
30
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
niversitair Medisch Centrum Sint Radboud

Eligibility Criteria

Inclusion Criteria

  • \- Receive a treatment for HIV\-infection
  • \- \> 18 years old
  • \- Current usage of inhalation or nasal corticosteroids
  • \- Willing to give informed consent

Exclusion Criteria

  • \- Known adrenal insufficiency
  • \- Concurrent use of topical corticosteroids, usage of oral corticosteroids in the last three months. Intramuscular or intra\-articular corticosteroid injections in the last year.
  • \- Contra\-indications for tetracosactide: allergy for tetracosactide, Cushings\*s syndrome, refractory heart failure, peptic ulcer, acute psychosis, adrenogenital syndrome
  • \- Pregnant female or breast\-feeding female.
  • \- Use of oral contraceptives, since these can heighten the cortisol\-binding globulin

Outcomes

Primary Outcomes

Not specified

Similar Trials